According to the UK SmPC for Wegovy, fatigue is classified as a 'common' side effect (affecting between 1 in 10 and 1 in 100 people)
The broader benefits beyond glucose control are increasingly recognised in clinical decision-making, though prescribing decisions should be individualised based on patient characteristics, comorbidities, and treatment goals
In clinical studies, GLP-1 administered intravenously to fasting patients failed to reduce blood sugar levels compared with patients who consumed a meal
Chronically elevated blood sugar reacts with enzymes and other protein molecules to create advanced glycation end-products (AGEs)
Description BPC157: Synthetic Peptide for Research Use BPC157 (Body Protection Compound157) is a synthetic peptide consisting of 15 amino acids , derived from a sequence found in gastric proteins
Insulin signaling impairment in the brain as a risk factor in alzheimers disease